CVR: 38968254
Devopharma ApS is a Danish company of the type Anpartsselskab based in Charlottenlund, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Henrik Nakskov and Søren Luplau-Pagh. The company's owners include JARCO HOLDING ApS, HN HOLDING 2010 ApS and Friendly Holding ApS. In 2025, the company reported a gross profit of DKK -3,125 and a net result of DKK -3,125 compared with DKK -3,125 the year before. Equity amounted to DKK 25,000.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at udøve virksomhed med forskning og eksperimentel udvikling indenfor bioteknologi
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreCompared to 1.051 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Devopharma ApS has published its annual report for 2025. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
As of January 15, 2026, JARCO HOLDING ApS is registered as an owner of Devopharma ApS with an ownership share of 15%.
As of January 15, 2026, GAIN ApS is registered as an owner of Devopharma ApS with an ownership share of 10%.
Devopharma ApS has published its annual report for 2024. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
Devopharma ApS has published its annual report for 2023. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
Devopharma ApS has published its annual report for 2022. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
Devopharma ApS has published its annual report for 2021. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
Devopharma ApS has published its annual report for 2020. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
As of June 30, 2021, MBA STATSAUTORISERET REVISIONSANPARTSSELSKAB has stepped down as auditor of Devopharma ApS.
Devopharma ApS has published its annual report for 2019. Gross profit came to DKK -3,125, and the net result was DKK -3,125.
Devopharma ApS has published its interim report for the period September 25, 2017 – December 31, 2018.
As of April 16, 2019, Morten Olesen has stepped down as director of Devopharma ApS.
As of April 16, 2019, Allan Anesteen Tharuman has stepped down as director of Devopharma ApS.
As of September 25, 2017, MBA STATSAUTORISERET REVISIONSANPARTSSELSKAB has been appointed auditor of Devopharma ApS.
As of September 25, 2017, Morten Olesen is registered as director of Devopharma ApS.
As of September 25, 2017, Allan Anesteen Tharuman is registered as director of Devopharma ApS.
As of September 25, 2017, Henrik Nakskov is registered as director of Devopharma ApS.
As of September 25, 2017, Søren Luplau-Pagh is registered as director of Devopharma ApS.
As of September 25, 2017, HN HOLDING 2010 ApS is registered as an owner of Devopharma ApS with an ownership share of 50%.
As of September 25, 2017, Friendly Holding ApS is registered as an owner of Devopharma ApS with an ownership share of 25%.
Devopharma ApS was founded on September 25, 2017.
Companies in the same industry and area
CVR 39691825
CVR 26413834
CVR 42845469
CVR 29015082
CVR 41215720
companydata.dk